Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease. Thromb Haemost. 2017 10 05; 117(10):1981-1988.
View in:
PubMed
subject areas
Adenosine
Adenosine
Aged
Aged
Blood Platelets
Blood Platelets
Cardiovascular Diseases
Cardiovascular Diseases
Coronary Thrombosis
Coronary Thrombosis
Cross-Over Studies
Cross-Over Studies
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2
Female
Female
Fibrinolytic Agents
Fibrinolytic Agents
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Platelet Function Tests
Platelet Function Tests
Ticlopidine
Ticlopidine
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber